Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Novel Hydrophilic Copolymer-Based Nanoparticle Enhances the Therapeutic Efficiency of Doxorubicin in Cultured MCF-7 Cells.

Naidu PSR, Norret M, Dunlop SA, Fitzgerald M, Clemons TD, Iyer KS.

ACS Omega. 2019 Oct 11;4(17):17083-17089. doi: 10.1021/acsomega.8b02894. eCollection 2019 Oct 22.

2.

Elucidating the Inability of Functionalized Nanoparticles to Cross the Blood-Brain Barrier and Target Specific Cells in Vivo.

Naidu PSR, Gavriel N, Gray CGG, Bartlett CA, Toomey LM, Kretzmann JA, Patalwala D, McGonigle T, Denham E, Hee C, Ho D, Taylor NL, Norret M, Smith NM, Dunlop SA, Iyer KS, Fitzgerald M.

ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22085-22095. doi: 10.1021/acsami.9b01356. Epub 2019 Jun 12.

PMID:
31150197
3.

Diminished responses to monoaminergic antidepressants but not ketamine in a mouse model for neuropsychiatric lupus.

Srikumar BN, Naidu PS, Kalidindi N, Paschapur M, Adepu B, Subramani S, Nagar J, Srivastava R, Sreedhara MV, Prasad DS, Das ML, Louis JV, Kuchibhotla VK, Dudhgaonkar S, Pieschl RL, Li YW, Bristow LJ, Ramarao M, Vikramadithyan RK.

J Psychopharmacol. 2019 Jan;33(1):25-36. doi: 10.1177/0269881118812102. Epub 2018 Nov 28.

PMID:
30484737
4.

BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder.

Marcin LR, Warrier J, Thangathirupathy S, Shi J, Karageorge GN, Pearce BC, Ng A, Park H, Kempson J, Li J, Zhang H, Mathur A, Reddy AB, Nagaraju G, Tonukunuru G, Gupta GVRKM, Kamble M, Mannoori R, Cheruku S, Jogi S, Gulia J, Bastia T, Sanmathi C, Aher J, Kallem R, Srikumar BN, Vijaya KK, Naidu PS, Paschapur M, Kalidindi N, Vikramadithyan R, Ramarao M, Denton R, Molski T, Shields E, Subramanian M, Zhuo X, Nophsker M, Simmermacher J, Sinz M, Albright C, Bristow LJ, Islam I, Bronson JJ, Olson RE, King D, Thompson LA, Macor JE.

ACS Med Chem Lett. 2018 Apr 13;9(5):472-477. doi: 10.1021/acsmedchemlett.8b00080. eCollection 2018 May 10.

5.

The Protein Corona of PEGylated PGMA-Based Nanoparticles is Preferentially Enriched with Specific Serum Proteins of Varied Biological Function.

Naidu PSR, Norret M, Smith NM, Dunlop SA, Taylor NL, Fitzgerald M, Iyer KS.

Langmuir. 2017 Nov 14;33(45):12926-12933. doi: 10.1021/acs.langmuir.7b02568. Epub 2017 Oct 30.

6.

Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive Disorder.

Bristow LJ, Gulia J, Weed MR, Srikumar BN, Li YW, Graef JD, Naidu PS, Sanmathi C, Aher J, Bastia T, Paschapur M, Kalidindi N, Kumar KV, Molski T, Pieschl R, Fernandes A, Brown JM, Sivarao DV, Newberry K, Bookbinder M, Polino J, Keavy D, Newton A, Shields E, Simmermacher J, Kempson J, Li J, Zhang H, Mathur A, Kallem RR, Sinha M, Ramarao M, Vikramadithyan RK, Thangathirupathy S, Warrier J, Islam I, Bronson JJ, Olson RE, Macor JE, Albright CF, King D, Thompson LA, Marcin LR, Sinz M.

J Pharmacol Exp Ther. 2017 Dec;363(3):377-393. doi: 10.1124/jpet.117.242784. Epub 2017 Sep 27.

PMID:
28954811
7.

Characterization of the adrenocorticotrophic hormone - induced mouse model of resistance to antidepressant drug treatment.

Srikumar BN, Paschapur M, Kalidindi N, Adepu B, Das ML, Sreedhara MV, Kuchibhotla VK, Pieschl RL, Li YW, Ega DSP, Louis JV, Murugesan S, Naidu PS, Ramarao M, Bristow LJ, Vikramadithyan RK.

Pharmacol Biochem Behav. 2017 Oct;161:53-61. doi: 10.1016/j.pbb.2017.09.003. Epub 2017 Sep 11.

PMID:
28911960
8.

Characterization of polymeric nanoparticles for treatment of partial injury to the central nervous system.

Lozić I, Hartz RV, Bartlett CA, Shaw JA, Archer M, Naidu PSR, Smith NM, Dunlop SA, Iyer KS, Kilburn MR, Fitzgerald M.

Data Brief. 2016 Feb 16;7:152-156. doi: 10.1016/j.dib.2016.02.019. eCollection 2016 Jun.

9.

Enabling dual cellular destinations of polymeric nanoparticles for treatment following partial injury to the central nervous system.

Lozić I, Hartz RV, Bartlett CA, Shaw JA, Archer M, Naidu PS, Smith NM, Dunlop SA, Iyer KS, Kilburn MR, Fitzgerald M.

Biomaterials. 2016 Jan;74:200-16. doi: 10.1016/j.biomaterials.2015.10.001. Epub 2015 Oct 9.

10.

Iodine-catalyzed sp³ C-H bond activation by selenium dioxide: synthesis of diindolylmethanes and di(3-indolyl)selanides.

Naidu PS, Majumder S, Bhuyan PJ.

Mol Divers. 2015 Nov;19(4):685-93. doi: 10.1007/s11030-015-9605-3. Epub 2015 May 28.

PMID:
26016723
11.

Reductive Alkylation of α-Keto Imines Catalyzed by PTSA/FeCl3: Synthesis of Indoles and 2,3'-Biindoles.

Naidu PS, Kolita S, Sharma M, Bhuyan PJ.

J Org Chem. 2015 Jun 19;80(12):6381-90. doi: 10.1021/acs.joc.5b00533. Epub 2015 Jun 5.

PMID:
26014372
12.

Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice.

Vijaya Kumar K, Rudra A, Sreedhara MV, Siva Subramani T, Prasad DS, Das ML, Murugesan S, Yadav R, Trivedi RK, Louis JV, Li YW, Bristow LJ, Naidu PS, Vikramadithyan RK.

Brain Behav Immun. 2014 Nov;42:204-11. doi: 10.1016/j.bbi.2014.06.205. Epub 2014 Jul 9.

PMID:
25016199
13.

Microwave-assisted one-pot multi-component reaction: synthesis of novel and highly functionalized 3-(pyranyl)- and 3-(dihydropyridinyl)indole derivatives.

Borah P, Naidu PS, Majumder S, Bhuyan PJ.

Mol Divers. 2014 Nov;18(4):759-67. doi: 10.1007/s11030-014-9533-7. Epub 2014 Jul 11.

PMID:
25012814
14.

Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.

Fowler CJ, Björklund E, Lichtman AH, Naidu PS, Congiu C, Onnis V.

J Enzyme Inhib Med Chem. 2013 Feb;28(1):172-82. doi: 10.3109/14756366.2011.643304. Epub 2012 Jan 6.

15.

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.

Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH.

Pharmacol Biochem Behav. 2011 Oct;99(4):718-25. doi: 10.1016/j.pbb.2011.06.022. Epub 2011 Jun 29.

16.

The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.

Kinsey SG, Mahadevan A, Zhao B, Sun H, Naidu PS, Razdan RK, Selley DE, Imad Damaj M, Lichtman AH.

Neuropharmacology. 2011 Feb-Mar;60(2-3):244-51. doi: 10.1016/j.neuropharm.2010.09.004. Epub 2010 Sep 16.

17.

Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.

Naidu PS, Kinsey SG, Guo TL, Cravatt BF, Lichtman AH.

J Pharmacol Exp Ther. 2010 Jul;334(1):182-90. doi: 10.1124/jpet.109.164806. Epub 2010 Apr 7.

18.

Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.

Booker L, Naidu PS, Razdan RK, Mahadevan A, Lichtman AH.

Drug Alcohol Depend. 2009 Nov 1;105(1-2):42-7. doi: 10.1016/j.drugalcdep.2009.06.009. Epub 2009 Aug 12.

19.

The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1.

Fowler CJ, Naidu PS, Lichtman A, Onnis V.

Br J Pharmacol. 2009 Feb;156(3):412-9. doi: 10.1111/j.1476-5381.2008.00029.x. Review.

20.

Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.

Naidu PS, Booker L, Cravatt BF, Lichtman AH.

J Pharmacol Exp Ther. 2009 Apr;329(1):48-56. doi: 10.1124/jpet.108.143487. Epub 2008 Dec 31.

21.

Protective effect of quercetin against ICV colchicine-induced cognitive dysfunctions and oxidative damage in rats.

Kumar A, Sehgal N, Kumar P, Padi SS, Naidu PS.

Phytother Res. 2008 Dec;22(12):1563-9. doi: 10.1002/ptr.2454.

PMID:
18980205
22.

Estimation of shape of binary polygonal object from scattered field.

Buvaneswari A, Naidu PS.

IEEE Trans Image Process. 1998;7(2):253-7. doi: 10.1109/83.661005.

PMID:
18267401
23.
24.

Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type.

Kumar A, Seghal N, Naidu PS, Padi SS, Goyal R.

Pharmacol Rep. 2007 May-Jun;59(3):274-83.

26.

Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.

Kumar P, Padi SS, Naidu PS, Kumar A.

Fundam Clin Pharmacol. 2007 Jun;21(3):297-306.

PMID:
17521299
27.

NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action.

Naidu PS, Lichtman AH, Archer CC, May EL, Harris LS, Aceto MD.

Eur J Pharmacol. 2007 Jul 2;566(1-3):132-6. Epub 2007 Mar 30.

28.

Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.

Kumar P, Padi SS, Naidu PS, Kumar A.

Methods Find Exp Clin Pharmacol. 2007 Jan-Feb;29(1):19-25.

PMID:
17344940
29.

Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.

Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH.

Psychopharmacology (Berl). 2007 May;192(1):61-70. Epub 2007 Feb 6.

PMID:
17279376
30.
31.

Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats.

Kumar A, Seghal N, Padi SV, Naidu PS.

Eur J Pharmacol. 2006 Dec 3;551(1-3):58-66. Epub 2006 Sep 9.

PMID:
17027965
32.
33.

Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action.

Dhir A, Naidu PS, Kulkarni SK.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1478-85. Epub 2006 Jul 17.

PMID:
16844276
34.

Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats.

Padi SS, Naidu PS, Kulkarni SK.

Inflammopharmacology. 2006 Mar;14(1-2):57-61.

PMID:
16835714
37.
38.
40.

Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions.

Joshi D, Naidu PS, Singh A, Kulkarni SK.

J Med Food. 2005 Fall;8(3):392-6.

PMID:
16176153
41.

PASS assisted search and evaluation of some azetidin-2-ones as C.N.S. active agents.

Goel RK, Singh A, Naidu PS, Mahajan MP, Kulkarni SK.

J Pharm Pharm Sci. 2005 Aug 3;8(2):182-9.

42.

Reversal of triazolam tolerance and withdrawal-induced hyperlocomotor activity and anxiety by bupropion in mice.

Joshi D, Naidu PS, Singh A, Kulkarni SK.

Pharmacology. 2005 Oct;75(2):93-7. Epub 2005 Jul 25.

PMID:
16088250
43.

Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice.

Dhir A, Naidu PS, Kulkarni SK.

Clin Exp Pharmacol Physiol. 2005 Jul;32(7):574-84.

PMID:
16026518
44.

Protective effect of bupropion on morphine tolerance and dependence in mice.

Joshi D, Singh A, Naidu PS, Kulkarni SK.

Methods Find Exp Clin Pharmacol. 2004 Oct;26(8):623-6.

PMID:
15605122
45.

FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.

Singh A, Naidu PS, Kulkarni SK.

Indian J Exp Biol. 2003 Nov;41(11):1264-8.

PMID:
15332494
46.

Antinociceptive action of FK506 in mice.

Singh A, Kumar G, Naidu PS, Kulkarni SK.

Indian J Exp Biol. 2003 Dec;41(12):1405-9.

PMID:
15320493
47.

D2-dopamine receptor and alpha2-adrenoreceptor-mediated analgesic response of quercetin.

Naidu PS, Singh A, Kulkarni SK.

Indian J Exp Biol. 2003 Dec;41(12):1400-4.

PMID:
15320492
48.

Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy.

Naidu PS, Kulkarni SK.

Methods Find Exp Clin Pharmacol. 2004 Jun;26(5):323-6.

PMID:
15319809
49.

Effect of FK506 (tacrolimus) in animal models of inflammation.

Singh A, Naidu PS, Patil CS, Kulkarni SK.

Inflammopharmacology. 2003;11(3):249-57.

PMID:
15035807
50.

Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid.

Singh A, Naidu PS, Kulkarni SK.

Free Radic Res. 2003 Nov;37(11):1245-52.

PMID:
14703737

Supplemental Content

Loading ...
Support Center